Tumor necrosis factor-α blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: Results of a multinational survey

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 1146-1150

  Foeldvari, Ivan ^a   Nielsen, Susanne ^b   Kümmerle Deschner, Jasmin ^c   Espada, Graciela ^d   Horneff, Gerd ^e   Bica, Blanca ^f   Olivieri, Alma N ^g   Wierk, Angela ^h   Saurenmann, Rotraud K ⁱ  

^a Klinikum Eilbek   (Germany)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^e Department of Pediatrics and Neonatology   (Germany)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h Allgemeinen Krankenhaus Eilbek   (Germany)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Juvenile idiopathic arthritis; Multinational survey; Treatment; Tumor necrosis factor antagonist; Uveitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ANAPHYLAXIS; CHI SQUARE TEST; CHILD; COHORT ANALYSIS; COMMUNITY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; E-MAIL; FEMALE; HUMAN; HYPERALGESIA; HYPOTENSION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PHYSICIAN; PRIORITY JOURNAL; REVIEW; RHEUMATOLOGY; SKIN HYPERALGESIA; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; UVEITIS;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; INTERNATIONAL COOPERATION; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 34248633648     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Cunningham ET. Uveitis in children. Ocul Immunol Inflamm 2000;8:251-61.
2. Kotaniemi K, Aho K, Koteniemi A. Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 2001;28:309-12.
3. Chylack LT. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum 1977;20:217-23.
4. Levy-Clarke GA, Nussenblatt RB, Smith JA. Management of chronic pediatric uveitis. Curr Opin Ophthalmol 2005;16:281-8.
5. Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in children. Int Ophthalmol Clin 2005;45:135-56.
6. Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005;32:362-5.
7. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8.
8. Lustig MJ, Cunningham ET Jr. Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol 2003;14:399-412.
9. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001;44:1411-5.
10. Vazquez-Cobian LB, et al. Treatment of resistant uveitis in children with adalimumab [abstract]. Arthritis Rheum 2003;48 Suppl:3630 SY 24.
11. Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003;110:1449-53.
12. Smith JA, Thompson DJ, Whitcup SM, et al. A randomized, placebo controlled double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005;53:18-23.
13. Saurenmann K, Rose J, Tyrell P, et al. The effects of anti-TNF-alpha treatment in children with uveitis [abstract]. Arthritis Rheum 2004;50 Suppl: p. S 92, A 79.
14. Tynjala P, Lindahl P, Honkanen V, Lahdenne P, Kotaniemi K. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 2006 Oct 20; Epub ahead of print.
15. Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006;113:2317-23. Epub 2006 Sep 25
16. Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology 2004;111:2299-306.
17. Wallace C, Ruperto N, Giannini E; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
18. Schmeling H, Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology Oxford 2005;44:1008-11.